UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Chimeric Antigen Receptor engineered gamma delta T cells for neuroblastoma immunotherapy

Capsomidis, Anna; (2020) Chimeric Antigen Receptor engineered gamma delta T cells for neuroblastoma immunotherapy. Doctoral thesis (Ph.D), UCL (University College London). Green open access

[thumbnail of Capsomidis_000_Thesis.pdf]
Preview
Text
Capsomidis_000_Thesis.pdf

Download (8MB) | Preview

Abstract

Gamma delta (γδ) T cells are a unique subset of lymphocytes that combine both innate and adaptive immune properties. They are primed for rapid function including tumour cell cytotoxicity, and following activation, have professional antigen presenting function. Chimeric antigen receptors (CARs) are synthetically engineered receptors that combine the specific antigen-binding region of a monoclonal antibody with a signalling domain responsible for T cell activation and cytotoxicity. Given the natural tissue tropism and innate cellular responses of γδ T cells, it was hypothesised that transduction with a CAR would enhance antigen-specific cytotoxicity, whilst maintaining direct antigen presenting function and the ability to migrate towards tumours. Using the tumour antigen GD2 as a model system, we demonstrated that Vδ1 and Vδ2 cells could be activated, propagated and transduced to sufficient number for use in clinical studies in paediatric patients. The addition of GD2-CAR, enhanced γδ T cell innate cytotoxicity through specific killing of GD2-expressing neuroblastoma cell lines. Migration towards tumour cells was not impaired by the presence of the CAR. Following activation, GD2-CAR transduced Vδ2 cells, retained the ability to take up exogenous tumour antigen, and cross-presented processed peptide to responder αβ T cells. This study provides evidence to support the emerging role of CAR γδ T cells as a safe and efficacious immunotherapy for neuroblastoma.

Type: Thesis (Doctoral)
Qualification: Ph.D
Title: Chimeric Antigen Receptor engineered gamma delta T cells for neuroblastoma immunotherapy
Event: UCL (University College London)
Open access status: An open access version is available from UCL Discovery
Language: English
Additional information: Copyright © The Author 2020. Original content in this thesis is licensed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) Licence (https://creativecommons.org/licenses/by/4.0/). Any third-party copyright material present remains the property of its respective owner(s) and is licensed under its existing terms. Access may initially be restricted at the author’s request.
UCL classification: UCL
UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
URI: https://discovery.ucl.ac.uk/id/eprint/10117317
Downloads since deposit
126Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item